BIOTYPE Upgrades Benchtop Diagnostic Platform for Multi-Gene Testing
BIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read MorePosted by Andy Lundin | Nov 14, 2023 | Molecular Diagnostic Analyzers |
BIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read MorePosted by Chris Wolski | Nov 14, 2023 | Breast |
PreciseBreast, an AI-powered digital morphology tool, has a fast turnaround time and is cost-effective compared to gene expression tests.
Read MorePosted by Andy Lundin | Nov 14, 2023 | Molecular Diagnostics |
A special kind of genetic testing that determines the best antidepressant for patients with depression may greatly improve patient outcomes.
Read MorePosted by Andy Lundin | Nov 7, 2023 | Company News, Molecular Diagnostics |
Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.
Read MorePosted by Andy Lundin | Nov 3, 2023 | Covid 19, Diagnostic Technologies, Swabs |
The prototype device uses lab-on-a-chip technology and has been proven to provide rapid and low-cost detection of COVID from nasal swabs.
Read More